Catalyst Biosciences Inc
CBIO - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$500.7M
Close$
$19.84
53.7% upside
Current Fair Value
53.7% upsideUndervalued by 53.7% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $500.70 Million |
|---|---|
| Enterprise Value | $333.66 Million |
| Earnings per Share | $-14.78 |
| Beta | 1.26 |
| Outstanding Shares | 30,532,234 |
Return
| Return on Equity | -76.25% |
|---|---|
| Return on Assets | -68.11% |
| Return on Invested Capital | -106.85% |
Valuation & Multiples
| P/E Ratio | -1.78 |
|---|---|
| PEG | 1.78 |
| Price to Sales | -12.91 |
| Price to Book Ratio | 2.58 |
| Enterprise Value to Revenue | -11.3 |
| Enterprise Value to EBIT | -1.9 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
$-0.74
Consensus analyst estimateRevenue Estimate
$357,143
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.67
Consensus analyst estimateRevenue Estimate
$357,143
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 95.52% |
|---|---|
| Total Invested | $2,511▼ 100.00% |
| Investors Holding | 4▼ 78.00% |
About Catalyst Biosciences Inc
CEO: Nassim Usman
